PTC Inc. is expanding with cloud-native tools and AI integration. Learn why PTC stock is a solid "Buy" on dips, driven by ...

In a significant move to tighten voting regulations, US President Donald Trump signed an executive order on Tuesday, ...

While analysts maintain optimism that these changes will ultimately enhance PTC's market position and sales capabilities, InvestingPro reports that 15 analysts have recently revised their earnings ...

PTC (NasdaqGS:PTC) experienced a 4.52% decline in its total shareholder returns over the past week, coinciding with the appointment of Trac Pham to its Board of Directors. Pham brings a strong record ...

While analysts maintain optimism that these changes will ultimately enhance PTC's market position and sales capabilities, InvestingPro reports that 15 analysts have recently revised their earnings ...

Proficio Capital Partners LLC purchased a new position in shares of PTC Inc. (NASDAQ:PTC – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 48,174 shares of the ...

New PTC Chief Partner Officer Kimberly King told CRN in an interview that she plans to simplify the industrial software vendor’s partner program and expand its reach through new engagements with ISVs ...

changes in tax and other laws, regulations, rates and policies; the eligible patient base and commercial potential of PTC's products and product candidates; PTC's scientific approach and general ...

PTC Therapeutics missed analyst estimates ... and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual.

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average recommendation of “Moderate Buy” ...

Learn more about whether PTC Therapeutics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...